Advertisement
Journal Home
Search for

Volume 36, Issue 1, Pages 64-71 (January 2007)


View previous. 14 of 18 View next.

Coccidioides immitis fungemia: Clinical features and survival in 33 adult patients

Presented in-part in Critical Care Medicine 2001;29:12 (supplement) A1061 and Critical Care Medicine 1999;27:A122.2

Silke Rempe, MDa, Mankanwal S. Sachdev, MDb, Rajesh Bhakta, MDc, Mauricio Pineda-Roman, MDd, Austin Vaz, MDe, Richard W. Carlson, MD, PhD, FCCMfgCorresponding Author Information

Coccidioides immitis is a fungus endemic to the southwestern United States. Susceptible hosts, including blacks, Hispanics, Filipinos, Native Americans, and those with compromised immunity, may develop disseminated disease, including fungemia. We retrospectively reviewed the records of all patients (n = 33) with Coccidioides immitis fungemia (CIF) at a 550-bed public hospital in Phoenix, Arizona, from 1990 to 2002. This is the largest reported series of CIF. The purpose of the study was to review the incidence, signs, symptoms, and outcomes of CIF. Twenty-nine patients had human immunodeficiency virus infection. CIF was associated with sepsis, end-stage alcoholic liver disease, and diabetes in four patients. Survival was poor; 24 of the 33 patients died within 28 days. CIF manifested as a systemic inflammatory response syndrome with progressive cardiorespiratory failure. Despite fluid loading, infusion of vasoactive agents, and mechanical ventilation with positive end-expiratory pressure, patients typically experienced a rapidly progressive course and death. CIF portends an ominous prognosis and typically occurs in the setting of advanced human immunodeficiency virus or medical or surgical crises.

a Pulmonary/Critical Care Carl T. Hayden VA Good Samaritan Medical Center, Phoenix, Arizona

b Hepatology Mayo Clinic-Scottsdale, Scottsdale, Arizona

c Premier Physicians, Goodyear, Arizona

d Hematology/Oncology Medical University of South Carolina, Charleston, South Carolina

e Rheumatology Section, University of Arizona College of Medicine, University Medical Center, Tucson, Arizona

f Department of Medicine, Maricopa Medical Center, Phoenix, Arizona

g Mayo Medical School and University of Arizona, Arizona

Corresponding Author InformationReprint requests: Richard W. Carlson, MD, PhD, FCCM, Chair, Department of Medicine, Maricopa Medical Center, 2601 E. Roosevelt, Rm 6-B-09, Phoenix, AZ 85008.

 All authors were at the Maricopa Medical Center at the time of their contribution to this article.

Drs. Sachdev and Rempe contributed equally to the article.

The authors state that this material has not received commercial support and is not under submission at another publication. We do not have any personal financial interests in the material.

PII: S0147-9563(06)00233-0

doi:10.1016/j.hrtlng.2006.10.001


View previous. 14 of 18 View next.

Advertisement